Frank Angella

About Frank Angella

Frank joined GroveStreet in 2001 and is a member of the firm’s Investment Committee. He leads investments across all segments of private equity and offers particular expertise in healthcare venture capital, mid-sized European buyouts and energy-focused private equity funds. He is a member of a number of fund advisory boards and works closely with clients on developing portfolio construction models and forecasting tools. Frank has served as a Visiting Executive at Harvard Business School, as a guest lecturer in the MBA class Venture Capital and Private Equity.Prior to joining GroveStreet, Frank was a Co-founder of Biocode Inc, a venture-backed biotech startup where he helped raise $15 million in venture capital over three rounds of financing. During his six-year tenure at Biocode, Frank held a number of executive roles, including 18 months as Managing Director, Asia, based in Singapore, and was a co-inventor on two patents. Previously, Frank spent three years in early-stage venture capital as an associate at Innotage Management and as an analyst in the healthcare group of Advent Venture Partners in London.Frank earned an MBA from Harvard Business School (Baker Scholar) and a BA, Interdisciplinary Studies, from the University of Virginia.

Experience

1. Managing Partner

   Grovestreet

   Jun 2001 — Present · Boston, MA, US

   Grove Street Advisors (GSA) is a private equity and venture capital fund investor focused on managing fully-customized, discretionary separate programs. GSA currently has in excess of USD $5 billion assets under management.

Education

• Harvard Business School

  MBA

  1999 — 2001

• University of Virginia

  BA, Interdisciplinary Studies

  1985 — 1989

Skills

• Entrepreneurship
• Venture Capital
• Strategy
• Valuation
• Alternative Investments
• Private Equity
• Financial Modeling
• Due Diligence
• Investments
• Growth Capital